Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Dexcom Inc
(NQ:
DXCM
)
74.65
+2.29 (+3.16%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Dexcom Inc
< Previous
1
2
3
4
5
6
7
8
9
...
22
23
Next >
S&P 500, Nasdaq 100 Mark Seventh Straight Positive Session, Strongest Week Since October 2023: Friday's Top Movers
Today 16:09 EDT
S&P 500 and Nasdaq 100 indices gain for seventh straight day, marking best weekly performance since October 2023 on positive economic data. SPY and QQQ close with modest daily gains while DIA has best...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
1 Growth Stock Down 43% to Buy Right Now
Today 7:17 EDT
Here's why DexCom should be on your radar after the company's share price plunged recently.
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
August 15, 2024
Via
Benzinga
Should You Buy the 3 Worst Nasdaq 100 Stocks Since the Tech Sector Selloff?
August 12, 2024
The tech sector began selling off in July as investors abandoned former higher fliers, leaving these three as the worst Nasdaq 100 stocks.
Via
InvestorPlace
Here's How Much You Would Have Made Owning DexCom Stock In The Last 15 Years
August 05, 2024
Via
Benzinga
Demystifying DexCom: Insights From 15 Analyst Reviews
July 29, 2024
Via
Benzinga
Behind the Scenes of DexCom's Latest Options Trends
July 29, 2024
Via
Benzinga
Despite its growth, NASDAQ:DXCM remains within the realm of affordability.
July 29, 2024
In the world of growth stocks, NASDAQ:DXCM shines as a value proposition.
Via
Chartmill
Should You Buy DexCom Stock After Its Post-Earnings Sell-Off?
August 08, 2024
DexCom now trades at a drastically lower earnings multiple than it has in the past.
Via
The Motley Fool
Jim Cramer: This Energy Stock Is A Buy, Stay Away From DexCom
August 08, 2024
The "Mad Money" host says Dexcom had "a real bad miss... they still really haven't fully explained why that is."
Via
Benzinga
These Stocks Just Dropped by 40% and 15% -- Should You Buy the Dip?
August 08, 2024
It might be a great time to buy low.
Via
The Motley Fool
Chips, Glorious Chips!
August 07, 2024
Someone's gotta make 'em, and someone's gotta buy 'em.
Via
The Motley Fool
Is It Time to Buy July's Worst-Performing Nasdaq Stocks?
August 07, 2024
These three Nasdaq stocks saw price drops of more than 35% last month. Are they good buys or too risky to touch today?
Via
The Motley Fool
Down 40% in 1 Day, Is DexCom Stock Still a Buy?
August 06, 2024
Competition and new growth headwinds could derail the stock even further.
Via
The Motley Fool
DoorDash And Exact Sciences Are Among Top 10 Large Cap Gainers Last Week (July 28-Aug 3): Are The Others In Your Portfolio?
August 04, 2024
Top 10 stocks with highest gains last week, including Exact Sciences, Alnylam Pharmaceuticals, Resmed, Coca-Cola Consolidated, DexCom, Sprouts Farmers Market, UL Solutions, Labcorp Holdings, C.H....
Via
Benzinga
As Diabetes Battle Heats Up, Spotlight Turns To Dexcom, Abbott
August 02, 2024
Dexcom is taking on bigger rival Abbott Laboratories with a continuous glucose monitor for non insulin users.
Via
Investor's Business Daily
Jim Cramer Says This Home Improvement Chain Is A Buy Ahead Of Fed Rate Cut Cycle: 'I Would Pick Some Up Tomorrow'
July 31, 2024
Jim Cramer recommends buying Blackstone Inc. (BX) due to its strong companies and expects Lowe's (LOW) stock to benefit from Federal Reserve's rate cut.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Top 3 Health Care Stocks That May Explode In Q3
July 31, 2024
Via
Benzinga
Market Momentum: Your Weekly Financial Forecast
July 30, 2024
Originally published at VolumeLeaders What to expect for July 29- August 02, 2024
Via
Benzinga
DexCom Stock Plunged Over 40% Last Week. Are Eli Lilly's and Novo Nordisk's Drugs to Blame?
July 30, 2024
DexCom faces several challenges, but GLP-1 drugs aren't big problems for the company right now.
Via
The Motley Fool
ON Semiconductor Posts Upbeat Earnings, Joins Oil States International, CommScope Holding And Other Big Stocks Moving Higher On Monday
July 29, 2024
Via
Benzinga
Is Beaten-Down Dexcom Stock a Buy on the Dip?
July 29, 2024
The market may have overreacted to a disappointing earnings report.
Via
The Motley Fool
2 Unstoppable Growth Stocks to Buy Right Now for Less Than $1,000
July 29, 2024
These profitable businesses have a lot to offer the long-term investor.
Via
The Motley Fool
2 Magnificent Growth Stocks to Buy Right Now
July 27, 2024
These top stocks are looking increasingly attractive for a long-term investment.
Via
The Motley Fool
S&P 500 Gains Over 1%; 3M Shares Jump After Q2 Results
July 26, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Dow Recovers Weekly Losses With 600-Point Pop
July 26, 2024
The Dow Jones Industrial Average is soaring today, up 608 points at last look and breaking into positive territory for the week.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Wall Street Enjoys Late-Week Rally On Benign Inflation Data, Dow Jones Eyes Best Session Of 2024, Tech Unwinding Stalls: What's Driving Markets Friday?
July 26, 2024
After a turbulent week in the markets, the bulls reclaimed dominance on Wall Street during Friday’s session, with indices and sectors trading in positive territory as investors welcomed the latest...
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Crude Oil Down Over 2%; Bristol Myers Squibb Posts Upbeat Q2 Results
July 26, 2024
Via
Benzinga
Exposures
Fossil Fuels
DexCom Faces Short-Term Challenges, But Market Growth Prospects Remain Strong: Analyst
July 26, 2024
DexCom reports Q2 sales of $1.004B, up 15% YoY, with adjusted EPS of $0.43, beating the $0.39 consensus. Despite lowering 2024 sales guidance to $4.00-$4.05B, William Blair maintains an Outperform...
Via
Benzinga
Why Saia Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session
July 26, 2024
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
22
23
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.